for educational and safety purposes
Multi-component blends and stacks; the peptide healing combos (GLOW, KLOW, Wolverine), lipotropic fat-loss shots, and fixed-dose drug combinations, listed with what's in each and where to get them.
107 sourced · 1 reference
5-Amino/MIC is a combination formulation that pairs the NNMT inhibitor 5-Amino-1MQ with the classic lipotropic trio MIC, namely methionine, inositol, and choline. It is designed to attack body fat from two directions at once; 5-Amino-1MQ reprograms fat-cell metabolism by raising NAD, while the MIC lipotropics support the liver's handling and export of fat. Popular in physique and weight-management circles, it bundles a modern metabolic target with time-tested fat-metabolism cofactors in a single stack.
The BPC-157/KPV/GHK-Cu Transdermal Serum unites three of the most respected regenerative peptides into a single topical formula built for skin, soft tissue, and recovery support. BPC-157 drives angiogenesis and tissue repair, the melanocortin fragment KPV delivers potent anti-inflammatory action, and the copper tripeptide GHK-Cu remodels collagen and rejuvenates the dermal matrix. Together they form a compelling, multi-pathway serum for anyone seeking accelerated healing and visibly healthier skin.
CJC-1295 / Ipamorelin is a classic synergistic peptide pairing that combines a long-acting GHRH analogue with a highly selective growth hormone secretagogue. Together they stimulate growth hormone release through two complementary pathways, amplifying the natural, pulsatile GH signal cleanly and without raising stress hormones. For those exploring GH-axis support, this stack is among the most refined and popular combinations.
GHK-Cu + Methylene Blue Tallow Balm is a thoughtfully built topical that stacks three skin-loving actives in a single rub-on jar rather than a needle. The copper peptide GHK-Cu signals collagen and elastin renewal, low-dose methylene blue delivers standout antioxidant and mild antimicrobial support, and a nutrient-rich beef tallow base deeply hydrates while carrying the actives in. For anyone who wants repair, firmness, and antioxidant defense in one gentle, easy-to-use balm, this blend is a genuinely appealing pick.
GLOW is a smartly built recovery blend that combines three of the best-known repair peptides, GHK-Cu, BPC-157, and TB-500, in a single vial. The logic is elegant; each covers a different slice of the healing process, so together they blanket far more ground than any one peptide could, from collagen and skin quality to tendon repair, blood-vessel growth, and cell migration. For all-around tissue support and recovery, GLOW is one of the most popular and well-reasoned peptide stacks around.
HERC (MTB) is a compounded amino acid blend engineered around the two levers endurance athletes care about most: blood flow and cellular energy. It pairs L-arginine and L-citrulline, which raise nitric oxide to widen vessels and improve muscle oxygenation, with L-carnitine, the carrier that ferries fatty acids into mitochondria for fuel, and L-glutamine for recovery and ammonia handling [1][2][6]. Each component rests on its own peer-reviewed evidence base, giving the blend a mechanistically grounded rationale [1][5][6]. It is supplied for laboratory research.
KLOW is a premium four-peptide recovery blend that unites the celebrated GHK-Cu, BPC-157, and TB-500 trio with the anti-inflammatory tripeptide KPV, addressing skin, gut, and connective-tissue repair alongside inflammation in one formulation. Each component contributes a distinct and complementary mechanism: GHK-Cu drives collagen and skin remodeling, BPC-157 supports tendon, ligament, and gut-lining repair, TB-500 promotes cell migration and new blood-vessel growth, and KPV calms the inflammatory signaling that slows healing. For anyone seeking a comprehensive, research-grounded approach to tissue recovery, KLOW is among the most complete blends available.
LGD-4033 + YK-11 is a research stack that pairs Ligandrol (LGD-4033), a selective androgen receptor modulator, with YK-11, a myostatin-modulating compound, to pursue muscle growth through two mechanisms at once. LGD-4033 activates the androgen receptor and has increased lean body mass in a human trial, while YK-11 raises follistatin to counteract myostatin, the natural brake on muscle growth. For researchers exploring maximal anabolic signaling, this dual-mechanism combination is a frequently discussed and potent pairing.
Lipo MIC Prime is a lipotropic injectable that combines the classic MIC nutrients (methionine, inositol, and choline) with L-carnitine and vitamin B12 to support fat metabolism and energy during weight management. The MIC compounds help the liver process and export fat, L-carnitine ferries fatty acids into the mitochondria to be burned, and B12 supports energy production and methylation. Bundling several complementary metabolic cofactors into one formulation, it is a convenient, nutrient-based adjunct to a diet-and-exercise program.
Lipo-MIC + NAD+ is a lipotropic injectable that pairs the fat-metabolizing MIC nutrients (methionine, inositol, and choline) with NAD+, the coenzyme at the center of cellular energy production. The MIC compounds help the liver package and export fat rather than store it, while NAD+ fuels mitochondrial energy metabolism and activates sirtuins involved in fat handling. Combining lipid support with a foundational energy coenzyme, it is a modern take on the classic lipotropic injection for those pursuing fat loss and vitality.
Lipo-Nex is a lipotropic injectable built around a high-carnitine base combined with choline, inositol, yohimbine, ATP, and vitamin B12, formulated to support fat mobilization and energy. L-carnitine shuttles fatty acids into the mitochondria to be burned, while yohimbine blocks the alpha-2 adrenoceptors that normally restrain fat release, an effect most pronounced in stubborn areas and in the fasted state. With its added stimulant character from yohimbine, Lipo-Nex is a targeted option for those seeking assertive metabolic and fat-mobilization support.
MNT (PMP) is a combination injectable and pre-workout formula that pairs nitric oxide precursors with a focused cognitive stack in a single shot. Arginine, citrulline, and the arginase inhibitor norvaline drive vasodilation and blood flow for a stronger pump, while citicoline, N-acetyl-L-tyrosine, and trimethylglycine sharpen focus and support drive under load. It is engineered as a two-in-one performance blend that delivers physical pump and mental clarity together.
Akriderm GK is a Russian triple ointment combining the potent corticosteroid betamethasone dipropionate with the antibiotic gentamicin and the antifungal clotrimazole, for inflamed skin with suspected bacterial or fungal involvement.
Bilberry Forte is a Russian tablet blend of bilberry fruit extract with rutin, zinc and B vitamins, sold for eye strain and visual acuity.
This is a two peptide injectable blend of BPC-157 and TB-500, sold as lyophilised powder for reconstitution and used for soft tissue injury recovery; both peptides have defined sequences and neither is an approved medicine anywhere.
BrainMax is a Russian two ingredient capsule combining meldonium with emoxypine succinate, sold for fatigue, attention and recovery after illness; both ingredients have a substantial Russian literature and essentially no independent international evidence.
This is a two peptide injectable blend of a growth hormone releasing hormone analogue and a ghrelin receptor agonist, sold as lyophilised powder for reconstitution and used to raise pulsatile growth hormone release.
Corvalol is a Soviet era household sedative combining a small dose of phenobarbital with ethyl bromisovalerate and peppermint oil, sold without prescription in Russia for anxiety, palpitations and difficulty sleeping.
Cytoflavin is a Russian four component metabolic preparation of succinic acid, inosine, nicotinamide and riboflavin, given as enteric tablets or intravenous infusion for cerebral ischaemia and encephalopathy.
Maxitrol is a combination eye drop of the corticosteroid dexamethasone with two antibiotics, neomycin and polymyxin B, used where eye inflammation coexists with a risk of bacterial infection.
Fosfogliv is a Russian two ingredient hepatoprotective capsule combining phosphatidylcholine with sodium glycyrrhizinate, the licorice-derived acid, marketed for chronic hepatitis and fatty liver.
Sofradex is a combined ear and eye drop containing two antibiotics, framycetin and gramicidin, together with the corticosteroid dexamethasone.
Genferon is a Russian suppository and spray combining recombinant interferon alfa-2b with benzocaine and taurine, sold for infections of the urogenital tract.
Nootrop is a capsule blend of glycine with gotu kola and ginkgo biloba extracts and four B vitamins, sold as a general cognition and calm supplement.
GPL Femme is a capsule combining six animal organ peptide extracts with alpha lipoic acid, sold as a women's anti ageing formula; the peptide portion is undefined extract rather than sequenced peptide.
GPL Man is a capsule combining six animal organ peptide extracts with alpha lipoic acid, sold as a men's anti ageing formula; the peptide portion is undefined extract rather than sequenced peptide.
Hepa-Health is an Ayurvedic multi herb tablet sold as liver support, built on the same botanical set as the long established Liv.52 style hepatoprotective formulas.
Oftalmoferon is a Russian combination eye drop of recombinant human interferon alfa-2b with the antihistamine diphenhydramine, used for viral conjunctivitis and keratitis.
Montlezir is a fixed combination of levocetirizine and montelukast for allergic rhinitis, pairing an H1 antihistamine with a leukotriene receptor antagonist.
Lovelas Forte is a Russian herbal capsule blend sold for erectile function and libido.
Power Duo ModaXL is a 250 mg tablet said to contain both modafinil and armodafinil in a single dose.
Neurobion is a fixed combination of vitamins B1, B6 and B12 sold as tablets or intramuscular ampoules for neuropathy symptoms.
Peptide Complex Pro 01 is a leave on skin lotion combining two animal organ peptide extracts with a ginseng derived antioxidant complex and rosemary oil, sold for the heart and arteries; it is a topical cosmetic style mixture rather than a peptide of known sequence.
Peptide Complex Pro 02 is a leave on skin lotion combining a brain tissue peptide extract with a ginseng derived antioxidant complex and grapefruit oil, sold for the nervous system; it is a topical mixture rather than a peptide of known sequence.
Peptide Complex Pro 03 is a leave on skin lotion combining a thymus peptide extract with a ginseng derived antioxidant complex and lavender and jasmine oils, sold for immune support; it is a topical mixture rather than a peptide of known sequence.
Peptide Complex Pro 04 is a leave on skin lotion combining cartilage and thymus peptide extracts with a ginseng derived antioxidant complex, sold for the spine and joints; it is a topical mixture rather than a peptide of known sequence.
Peptide Complex Pro 06 is a leave on skin lotion combining four animal organ peptide extracts with a ginseng derived antioxidant complex and cinnamon oil, sold for the male reproductive system; it is a topical mixture rather than a peptide of known sequence.
Peptide Complex Pro 07 is a leave on skin lotion combining vascular, brain and thymus peptide extracts with a ginseng derived antioxidant complex and sandalwood oil, sold for the female reproductive system; it is a topical mixture rather than a peptide of known sequence.
Peptide Complex Pro 11 is a leave on skin lotion combining thymus, kidney and bladder peptide extracts with a ginseng derived antioxidant complex and oregano oil, sold for the urinary tract; it is a topical mixture rather than a peptide of known sequence.
Peptide Complex Pro 13 is a leave on skin lotion combining vascular, brain and eye tissue peptide extracts with a ginseng derived antioxidant complex and chamomile oil, sold for the eyes and ears; it is a topical mixture rather than a peptide of known sequence.
Omaron is a fixed combination of 400 mg piracetam and 25 mg cinnarizine, sold across the CIS for cerebrovascular complaints and vertigo.
Systane Ultra is an artificial tear whose two demulcents, polyethylene glycol 400 at 0.4 percent and propylene glycol at 0.3 percent, are held on the eye by a hydroxypropyl guar gelling system.
Revilab Anti-A.G.E. is an oral antioxidant capsule aimed at glycation of skin collagen and elastin.
Revilab SL 01 is a sublingual drop combining two animal organ peptide extracts with licorice, propolis, mint and chamomile extracts and two essential oils, sold for the cardiovascular system; it is a proprietary mixture rather than a peptide of known sequence.
Revilab SL 02 is a sublingual drop combining brain, retina and vascular peptide extracts with herbal extracts and essential oils, sold for the nervous system and vision; it is a proprietary mixture rather than a peptide of known sequence.
Revilab SL 03 is a sublingual drop combining pineal and two immune tissue peptide extracts with herbal extracts and essential oils, sold for immune and neuroendocrine support; it is a proprietary mixture rather than a peptide of known sequence.
Revilab SL 04 is a sublingual drop combining immune, cartilage and muscle peptide extracts with herbal extracts and essential oils, sold for muscles, bones and joints; it is a proprietary mixture rather than a peptide of known sequence.
Revilab SL 05 is a sublingual drop combining liver, pancreas and lung peptide extracts with herbal extracts and essential oils, sold for the digestive system and lungs; it is a proprietary mixture rather than a peptide of known sequence.
Revilab SL 06 is a sublingual drop combining immune, bronchial and lung peptide extracts with herbal extracts and essential oils, sold for the respiratory system; it is a proprietary mixture rather than a peptide of known sequence.
Revilab SL 07 is a sublingual drop combining immune, bone marrow and vascular peptide extracts with folic acid and vitamin B12, sold for the blood forming system; it is a proprietary mixture rather than a peptide of known sequence.
Revilab SL 08 is a sublingual drop combining immune, vascular and bladder peptide extracts with herbal extracts and essential oils, sold for the urinary system; it is a proprietary mixture rather than a peptide of known sequence.
Revilab SL 09 is a sublingual drop combining pineal, testis, bladder and prostate peptide extracts with herbal extracts and essential oils, sold for men's health; it is a proprietary mixture rather than a peptide of known sequence.
Revilab SL 10 is a sublingual drop combining pineal, vascular and bladder peptide extracts with herbal extracts and essential oils, sold for women's health; it is a proprietary mixture rather than a peptide of known sequence.
Selank + Semax is a nasal spray pairing two Russian research peptides that are normally sold on their own. Selank is a synthetic relative of the immune peptide tuftsin, studied in Russia as an anxiolytic that does not sedate and does not appear to produce the tolerance or withdrawal that benzodiazepines do. Semax is a shortened fragment of ACTH, cut so that it keeps the behavioural effects without the hormonal ones, and studied for attention, stroke recovery and neuroprotection. Both are reported to raise BDNF, and that shared thread is the usual argument for combining them: one takes the edge off, the other sharpens.
Spermstrong is a Russian capsule blend of amino acids, antioxidant vitamins and trace minerals sold to improve sperm count and motility.
This is the fixed three drug HIV regimen of tenofovir disoproxil fumarate, emtricitabine and efavirenz, the generic equivalent of Atripla.
Testogenon is a Russian herbal and amino acid capsule sold on the claim that it raises the body's own testosterone.
Tobradex is a combination eye drop of the aminoglycoside tobramycin with the corticosteroid dexamethasone, used for eye inflammation where bacterial infection is present or likely.
Thealoz Duo is a preservative free dry eye drop combining trehalose, a disaccharide that protects cells against desiccation, with sodium hyaluronate as a lubricant.
Zorex is a Russian capsule pairing the chelator unithiol with calcium pantothenate, sold for hangover and as support during alcohol withdrawal.
Vinpotropile is a Russian fixed combination of vinpocetine and piracetam sold for cerebrovascular complaints and memory problems.
The Wolverine Stack is a popular regenerative peptide combination that pairs BPC-157 with TB-500, named for the comic-book mutant famous for his near-instant healing. It brings together two of the most sought-after recovery peptides: BPC-157, a gastric peptide that accelerates tendon, ligament, muscle, and gut healing, and TB-500, a thymosin beta-4 peptide that drives cell migration and new blood vessel growth. Marketed to athletes and biohackers chasing faster injury recovery, the stack is prized for its complementary, tissue-repairing effects.
Adapalene/benzoyl peroxide is a fixed-dose combination medication for acne vulgaris that pairs the topical retinoid adapalene with the antimicrobial and keratolytic agent benzoyl peroxide in a single gel. Marketed under brand names such as Epiduo, it is applied to the skin and brings together two ingredients that act on different causes of acne. Combining them in one product targets several of the factors behind acne at once and can work faster than either ingredient used alone.
Amoxicillin/clavulanic acid, often called co-amoxiclav and sold under the brand name Augmentin, is a combination antibiotic that pairs the penicillin amoxicillin with clavulanic acid, a beta-lactamase inhibitor. The clavulanic acid shields amoxicillin from enzymes that many bacteria use to destroy it, so the combination works against infections that plain amoxicillin cannot [1]. It is used for conditions such as sinus infections, respiratory infections, and animal or human bites, but carries a higher risk of digestive upset and, uncommonly, liver injury than amoxicillin alone [2][3].
Aspirin + Atorvastatin is a fixed-dose combination medicine that pairs low-dose aspirin, an antiplatelet drug, with atorvastatin, a cholesterol-lowering statin. It is used mainly to prevent cardiovascular events such as heart attacks and strokes in people who already have, or are at high risk of, cardiovascular disease. Combining the two drugs in a single pill is intended to simplify treatment and improve adherence, and such fixed-dose combinations underpin the wider polypill approach to cardiovascular prevention.
Avanafil + Dapoxetine is a fixed-dose combination that pairs avanafil, a fast-acting PDE5 inhibitor for erectile dysfunction, with dapoxetine, a short-acting selective serotonin reuptake inhibitor used to delay ejaculation. It is marketed in some countries as an on-demand treatment for men who have both erectile dysfunction and premature ejaculation. Each ingredient is well studied on its own, but the combination product itself has little dedicated clinical trial data.
Azelastine + Fluticasone Propionate is a combination nasal spray, sold under the brand name Dymista, that delivers an antihistamine (azelastine) and a corticosteroid (fluticasone propionate) together from a single device. It is used to treat allergic rhinitis, the nasal and eye symptoms of hay fever and other allergies. By pairing two drugs with different actions it relieves symptoms such as congestion, runny nose, sneezing, and itching more completely and more quickly than either component alone.
Bacitracin zinc, neomycin, and polymyxin B is a topical antibiotic combination, sold over the counter as triple antibiotic ointment under brand names such as Neosporin. Blended into a petroleum-jelly base, the three antibiotics attack bacteria in complementary ways and together cover a wide range of gram-positive and gram-negative organisms. It is applied to minor cuts, scrapes, and burns to lower the chance of skin infection while a wound heals.
Bempedoic acid plus ezetimibe is a fixed-dose combination tablet that pairs two non-statin cholesterol-lowering drugs, marketed as Nexlizet in the United States and Nustendi in Europe. Bempedoic acid curbs the liver's production of cholesterol while ezetimibe blocks cholesterol absorption in the gut, so together they lower LDL cholesterol more than either does alone. The combination is used for people who need additional LDL reduction, particularly those who cannot tolerate statins or have not reached their targets on them.
Budesonide + Formoterol is a fixed-dose combination inhaler that pairs budesonide, an inhaled corticosteroid, with formoterol, a fast-acting long-acting beta-2 agonist. It is used to control asthma and chronic obstructive pulmonary disease (COPD), both as regular maintenance treatment and, in some regimens, as an as-needed reliever. Marketed under brand names such as Symbicort, it received United States approval in 2006 and is on the World Health Organization's List of Essential Medicines.
Calcium carbonate plus vitamin D3 is a combination dietary supplement that pairs calcium carbonate, a common calcium salt, with cholecalciferol (vitamin D3), the nutrient that helps the body absorb and use calcium. It is one of the most widely used supplements for supporting bone health and is commonly recommended to help prevent osteoporosis and bone loss, particularly in older adults and postmenopausal women. Because calcium carbonate is also an antacid, the combination is sold over the counter in many forms.
Citicoline with piracetam is a combination of two nootropic compounds sometimes taken together for cognitive support. Citicoline, also called cytidine diphosphate choline, is a naturally occurring precursor used to build brain cell membranes and the neurotransmitter acetylcholine, while piracetam is a synthetic derivative of GABA and the original member of the racetam family. The pairing is popular in nootropic circles, although the two ingredients have been studied mainly on their own rather than as a fixed combination.
Clopidogrel plus aspirin is a combination of two antiplatelet drugs, known as dual antiplatelet therapy, used to make blood clots less likely in people at high cardiovascular risk [1][2][3]. The two medicines block platelet activation by different routes, so together they inhibit clotting more completely than either alone [1][2]. The combination is a standard treatment after coronary stent placement and in acute coronary syndromes, and short courses are used soon after a minor ischaemic stroke or transient ischaemic attack; the added protection comes at the cost of a higher bleeding risk [3][4][5].
Cyproterone acetate / ethinylestradiol is a combination medication that pairs cyproterone acetate, a progestin with strong antiandrogen activity, with ethinylestradiol, a synthetic estrogen. Sold under brand names such as Diane-35 and Dianette, it is used mainly to treat androgen-related skin conditions in women, including moderate to severe acne, seborrhea, and excess hair growth (hirsutism), while also acting as a hormonal contraceptive. Because it carries a higher risk of blood clots than some other combined pills, its use is generally reserved for these specific indications rather than contraception alone.
Dextromethorphan/bupropion is a fixed-dose combination medicine used to treat major depressive disorder in adults. Sold under the brand name Auvelity and developed by Axsome Therapeutics, it was approved by the United States Food and Drug Administration in 2022. The product pairs dextromethorphan, which blocks NMDA glutamate receptors and activates sigma-1 receptors, with bupropion, an established antidepressant that also slows the breakdown of dextromethorphan so that useful levels are maintained. It is taken as an extended-release oral tablet and is a prescription medicine that is not a controlled substance.
Emtricitabine and tenofovir alafenamide is a fixed-dose combination of two antiretroviral drugs used to treat and to prevent HIV infection. Both are reverse-transcriptase inhibitors that block the enzyme HIV uses to copy its genetic material. Taken as a once-daily tablet and sold as Descovy, the combination has smaller effects on kidney function and bone density than an older tenofovir formulation.
Fluticasone furoate combined with azelastine is a combination nasal spray used to treat allergic rhinitis, marketed under the brand name Ryaltris. It pairs two different kinds of allergy medicine in a single device: azelastine, an antihistamine, and fluticasone furoate, a corticosteroid. The aim is to tackle the sneezing, itching, runny nose, and congestion of hay fever from more than one direction at once. Both ingredients act locally in the nose rather than throughout the body.
Furosemide combined with amiloride is a fixed-dose diuretic preparation that pairs two agents with complementary actions on the kidney, known generically as co-amilofruse and sold under names such as Frumil. Furosemide is a powerful loop diuretic that clears excess fluid but causes the body to lose potassium, while amiloride is a milder potassium-sparing diuretic that counteracts that loss. The combination is used to treat fluid retention, or oedema, as in heart failure, while helping to keep blood potassium from falling too low. Both components appear individually on the World Health Organization's List of Essential Medicines.
Glimepiride and metformin is a fixed-dose combination medication used to treat type 2 diabetes mellitus, pairing two oral glucose-lowering drugs with complementary actions. Metformin is a biguanide that lowers blood sugar chiefly by reducing glucose production in the liver and improving insulin sensitivity, while glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin. Combining them in a single tablet is intended to improve blood-sugar control and simplify treatment for people whose diabetes is not adequately managed by one agent alone.
Glutathione and kojic acid is a combination of two agents used together in cosmetic skin-lightening and brightening products. Glutathione is a naturally occurring antioxidant tripeptide that can shift melanin production toward lighter pigments, while kojic acid is a fungal-derived compound that inhibits tyrosinase, the key enzyme in melanin synthesis. Marketed in creams, soaps, and oral supplements, the pairing is intended to reduce hyperpigmentation and even out skin tone, although the strength of the clinical evidence varies.
Glutathione, kojic acid, and glycolic acid is a three-ingredient combination used in cosmetic skin-lightening and brightening formulations. It joins two agents that reduce melanin production, the antioxidant peptide glutathione and the tyrosinase inhibitor kojic acid, with glycolic acid, an alpha-hydroxy acid that exfoliates the surface of the skin. The blend is designed to fade hyperpigmentation and improve skin tone and texture by combining pigment-reducing and exfoliating actions.
Hydroquinone + Octinoxate + Oxybenzone is a combined topical preparation that pairs the skin-lightening agent hydroquinone with two organic ultraviolet filters, octinoxate and oxybenzone. It is used to treat melasma and other facial hyperpigmentation, with hydroquinone fading existing pigment while the sunscreen filters shield the treated skin from the ultraviolet light that darkens it. The formula reflects the standard clinical principle that pigment-lightening therapy works best alongside daily photoprotection.
Hydroquinone + Tretinoin + Fluocinolone Acetonide is a triple-combination topical cream used to treat melasma, a chronic facial hyperpigmentation. It brings together a depigmenting agent (hydroquinone), a retinoid (tretinoin) and a low-potency corticosteroid (fluocinolone acetonide) in a single formulation. Marketed in the United States as Tri-Luma and rooted in the older Kligman formula, it is widely regarded as one of the most effective topical treatments for melasma.
Hydroquinone + Tretinoin + Mometasone is a triple-combination topical cream used to lighten melasma and other facial hyperpigmentation. It is a modified version of the classic Kligman formula, pairing the depigmenting agent hydroquinone and the retinoid tretinoin with mometasone, a stronger corticosteroid than the fluocinolone used in the original. The formulation is widely prescribed and sold in some regions, though the more potent steroid raises particular safety concerns.
Levodopa + carbidopa is a fixed-dose combination medication used chiefly to treat Parkinson's disease. Levodopa is a precursor that the brain converts into dopamine, the neurotransmitter that is depleted in the disease, while carbidopa prevents levodopa from being broken down before it reaches the brain. Sold under brand names such as Sinemet, the pairing remains the most effective symptomatic treatment for Parkinson's disease.
Lisinopril + hydrochlorothiazide is a fixed-dose combination medication that pairs an ACE inhibitor with a thiazide diuretic in a single tablet to treat high blood pressure. Lisinopril relaxes blood vessels by blocking the angiotensin-converting enzyme, while hydrochlorothiazide helps the kidneys remove excess salt and water. Combining the two lowers blood pressure more than either alone and is typically used when a single drug is not enough. It is sold under brand names such as Zestoretic and Prinzide.
Losartan/hydrochlorothiazide is a fixed-dose combination antihypertensive that pairs the angiotensin II receptor blocker losartan with the thiazide diuretic hydrochlorothiazide in a single tablet. Sold under names such as Hyzaar, it is used to lower blood pressure when one drug is not enough. The two ingredients act through complementary mechanisms, so the combination usually lowers blood pressure more than either component on its own.
Minoxidil + Aminexil is a combination approach to pattern hair loss that pairs minoxidil, a topical vasodilator and established hair-growth agent, with aminexil, a structurally related molecule developed by the cosmetics industry to counter the fibrosis that can loosen hair at the root. Minoxidil is the better-evidenced of the two, while aminexil (also called kopexil) appears mainly in cosmetic anti-hair-loss formulations. The pairing is used topically for androgenetic alopecia rather than being a single approved drug.
Minoxidil + Finasteride is a combination therapy widely used for male androgenetic alopecia that pairs two agents with complementary actions: minoxidil, a topical vasodilator that stimulates the hair follicle, and finasteride, a 5-alpha-reductase inhibitor that lowers levels of the androgen dihydrotestosterone (DHT). Together they address both the follicle and the hormonal driver of pattern hair loss, and clinical studies generally find the combination more effective than either drug alone. The two are used together as oral finasteride with topical minoxidil, or in combined topical formulations.
Olmesartan plus amlodipine plus hydrochlorothiazide is a fixed-dose antihypertensive tablet that combines three blood-pressure medicines with complementary actions: the angiotensin II receptor blocker olmesartan medoxomil, the dihydropyridine calcium channel blocker amlodipine, and the thiazide diuretic hydrochlorothiazide. The single-pill regimen is intended for adults whose high blood pressure is not adequately controlled on a two-drug combination, and in the United States it is marketed under the brand name Tribenzor. By pairing agents that act on different parts of the cardiovascular system, the tablet is designed to lower blood pressure more fully while reducing the number of pills a person must take.
Olmesartan medoxomil plus azelnidipine is a fixed-dose antihypertensive tablet that combines an angiotensin II receptor blocker with a dihydropyridine calcium channel blocker. Marketed chiefly in Japan under the brand name Rezaltas, it pairs olmesartan, which relaxes blood vessels by blocking the AT1 receptor, with azelnidipine, a calcium channel blocker noted for its gradual onset and minimal effect on heart rate. The single-pill format is used to control blood pressure in patients for whom one drug is not enough, delivering two complementary agents in one daily tablet.
Olmesartan medoxomil plus hydrochlorothiazide is a fixed-dose antihypertensive tablet that combines an angiotensin II receptor blocker with a thiazide diuretic. It is used to treat high blood pressure in adults whose pressure is not controlled by olmesartan or a diuretic alone, and it is sold under brand names such as Benicar HCT and Olmetec Plus. Pairing the two drugs lets their blood-pressure-lowering effects add together while the receptor blocker helps counter the potassium loss that a diuretic can cause.
Olmesartan medoxomil plus metoprolol is a fixed-dose tablet that combines an angiotensin II receptor blocker with a cardioselective beta blocker. It brings together olmesartan, which lowers blood pressure by relaxing blood vessels, and metoprolol, which slows the heart and reduces its workload by blocking beta-1 adrenergic receptors. The combination is used mainly for high blood pressure in patients who also benefit from a beta blocker, such as those with certain heart rhythm problems, angina, or a history of heart attack, and it is marketed as a single-pill product in countries including India.
Pioglitazone plus metformin is a fixed-dose combination tablet that unites two oral diabetes medicines with complementary actions: pioglitazone, a thiazolidinedione that makes tissues more sensitive to insulin, and metformin, a biguanide that mainly reduces the amount of glucose released by the liver. It is used to improve blood sugar control in adults with type 2 diabetes whose condition is not adequately managed on metformin alone. Combining the two drugs in a single pill is intended to lower blood sugar more fully while simplifying treatment, and it is marketed under names such as ACTOplus Met and Competact.
Pregabalin with nortriptyline and methylcobalamin is a fixed-dose combination product used mainly for nerve pain, particularly the painful diabetic peripheral neuropathy commonly treated in South Asia, where such combinations are widely marketed. It brings together three ingredients with different roles: pregabalin, a gabapentinoid that calms overactive nerve signalling; nortriptyline, a tricyclic antidepressant long used for neuropathic pain; and methylcobalamin, an active form of vitamin B12 involved in nerve health. It is not sold as a single approved medicine in regions such as the United States or Europe, and the supporting evidence comes largely from studies of its individual components.
Rabeprazole plus domperidone is a fixed-dose combination medicine that pairs two drugs acting on the upper digestive tract: rabeprazole, a proton pump inhibitor that suppresses stomach acid, and domperidone, a prokinetic and antiemetic that speeds the movement of food out of the stomach. The combination is used mainly for acid reflux and related conditions accompanied by nausea, bloating, or slow gastric emptying. It is marketed in India and various other countries, often as a single capsule, but it is not approved in the United States, where domperidone itself is unlicensed.
Sildenafil plus dapoxetine is a pairing of two oral drugs used together in men who have both erectile dysfunction and premature ejaculation. Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that improves erectile function, while dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) developed specifically to delay ejaculation. The pairing targets the two most common male sexual complaints at once, and fixed-dose tablets combining them are marketed in some countries.
Sildenafil plus duloxetine refers to the combined use of a phosphodiesterase type 5 (PDE5) inhibitor and a serotonin-norepinephrine reuptake inhibitor (SNRI) in men who have both erectile dysfunction and premature ejaculation. Sildenafil improves erectile function, while duloxetine, primarily an antidepressant and pain medication, has been studied off-label for its ability to delay ejaculation. The pairing follows a broader strategy of combining a reuptake inhibitor with a PDE5 inhibitor to treat both problems together.
Sildenafil plus fluoxetine is the combined use of a phosphodiesterase type 5 (PDE5) inhibitor and a selective serotonin reuptake inhibitor (SSRI) in men with both erectile dysfunction and premature ejaculation. Sildenafil improves erectile function, while fluoxetine, a long-acting SSRI antidepressant, delays ejaculation as a side effect that is used off-label for premature ejaculation. Studies suggest the pairing can outperform either agent alone in appropriately selected men.
Sildenafil plus tadalafil is the combined use of two phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction, typically a longer-acting daily tadalafil together with on-demand sildenafil. The strategy is generally reserved for men who respond poorly to a single PDE5 inhibitor. Because both drugs share the same basic mechanism, combining them mainly extends coverage rather than adding a new mode of action.
Sodium valproate combined with valproic acid is the formulation known as valproate semisodium or divalproex sodium, sold chiefly under the brand name Depakote. It is a stable one-to-one complex of the two forms that dissociates in the gut to release the same active valproate ion. It is used as an anticonvulsant and mood stabilizer, most notably for the manic episodes of bipolar disorder, and is often chosen for its gentler effect on the stomach.
Sulfamethoxazole and trimethoprim, given together as a fixed-dose combination known as co-trimoxazole, is a widely used antibiotic. The two drugs block successive steps in the pathway bacteria use to make folate, producing a synergistic effect stronger than either alone. It treats infections including urinary tract infections, certain respiratory and skin infections, and is a first-line agent for Pneumocystis pneumonia in people with weakened immune systems.
Tadalafil plus dapoxetine is a fixed-dose combination that pairs two medicines with complementary effects on male sexual function. Tadalafil is a long-acting PDE5 inhibitor that improves erections, while dapoxetine is a short-acting selective serotonin reuptake inhibitor used to delay ejaculation. Marketed under names such as Tadapox, the combination is aimed at men who have both erectile dysfunction and premature ejaculation and is taken on demand before sexual activity.
Telmisartan with cilnidipine and chlorthalidone is a fixed-dose combination medicine that unites three blood-pressure-lowering drugs with complementary actions in a single tablet. It pairs an angiotensin II receptor blocker (telmisartan), a dual L-type and N-type calcium channel blocker (cilnidipine), and a thiazide-like diuretic (chlorthalidone). Single-pill combinations of this kind are used when hypertension is not adequately controlled by one or two agents, and they aim to simplify treatment and improve adherence.
Telmisartan + Nebivolol is a fixed-dose antihypertensive combination that pairs telmisartan, a long-acting angiotensin II receptor blocker, with nebivolol, a highly beta-1-selective, vasodilating beta-blocker. The two drugs lower blood pressure by complementary routes: telmisartan interrupts the renin-angiotensin-aldosterone system, while nebivolol slows the heart and relaxes blood vessels partly by promoting nitric oxide release. The product is marketed mainly as a single pill for people whose hypertension is better controlled when renin-angiotensin blockade is joined with heart-rate and sympathetic control.
Tenofovir Disoproxil Fumarate + Emtricitabine is a fixed-dose antiretroviral combination, sold under the brand name Truvada and as many generics, that unites two nucleoside and nucleotide reverse-transcriptase inhibitors active against HIV. Emtricitabine is a cytidine analogue, while tenofovir disoproxil fumarate is an orally absorbed prodrug of the adenine nucleotide analogue tenofovir; together they block the enzyme HIV uses to copy its genetic material. The tablet is taken once daily, both as part of combination treatment for HIV infection and, since 2012, as pre-exposure prophylaxis to lower the risk of acquiring HIV [1][2].
Vardenafil plus dapoxetine is a combination of two drugs used together to treat men who have both erectile dysfunction and premature ejaculation. Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor that improves erections, while dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) that delays ejaculation. The pairing is taken on demand before sexual activity and is marketed as a fixed-dose combination in some countries.
RAD-140 (Testolone) plus YK-11 is a popular bodybuilding stack that pairs two selective androgen receptor modulators (SARMs) sought for rapid gains in muscle mass and strength [1]. RAD-140 is a potent nonsteroidal androgen receptor agonist designed to drive muscle growth with fewer of the prostate and hormonal effects of testosterone, while YK-11 is a steroidal SARM marketed as a myostatin-modulating muscle-builder [1][7]. Both are investigational research chemicals, not approved drugs, and both are banned in sport; importantly, RAD-140 has been linked in case reports to serious cardiac harm, so the stack carries real risk [1][2][3].